This company has been acquired
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Taisho Pharmaceutical Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Taisho Pharmaceutical Holdings has a total shareholder equity of ¥857.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1,005.5B and ¥148.2B respectively. Taisho Pharmaceutical Holdings's EBIT is ¥18.9B making its interest coverage ratio -4. It has cash and short-term investments of ¥266.4B.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
JP¥0
Schuld
| Rente dekkingsratio | -4x |
| Contant | JP¥266.37b |
| Aandelen | JP¥857.30b |
| Totaal verplichtingen | JP¥148.17b |
| Totaal activa | JP¥1.01t |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: TAIS.F's short term assets (¥416.8B) exceed its short term liabilities (¥80.8B).
Langlopende schulden: TAIS.F's short term assets (¥416.8B) exceed its long term liabilities (¥67.3B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: TAIS.F is debt free.
Schuld verminderen: TAIS.F has not had any debt for past 5 years.
Schuldendekking: TAIS.F has no debt, therefore it does not need to be covered by operating cash flow.
Rentedekking: TAIS.F has no debt, therefore coverage of interest payments is not a concern.